DGAP-News: Cytos Biotechnology Ltd First Quarter Report 2010
(firmenpresse) - Cytos Biotechnology AG / Quarter Results
22.04.2010 06:45
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Cytos Biotechnology Ltd First Quarter Report 2010 as of March 31, 2010
Summary of important events in Q1 2010
- Partner Novartis starts a further placebo-controlled phase II study
with the vaccine candidate CAD106 in 120 Alzheimer's disease patients
- Change of Chairmanship in the Board of Directors
- Jakob Schlapbach (59) will resign as CFO during the year 2010 and will
be proposed to become a member of the Board of Directors
- Upcoming events:
- Presentation at the Vaccine Innovation, April 28-29, 2010 in
Frankfurt, Germany
- Presentation at the EAACI London 2010, June 5-9, 2010 in London, UK
- Presentation at the Active Immunotherapeutics Forum, June 21-23,
2010 in Barcelona, Spain
- Financial summary
in CHF million Q1 2010 Q1 2009The complete First Quarter Report can be downloaded on Cytos
Revenue 0.3 0.3
Net operating costs (6.9) (11.0)
Net loss (3.8) (11.8)
03/31/10 12/31/09
Cash, cash equivalents, 47.9 60.5
financial assets and
trade receivables
Full-time employees (number) 82 85
Biotechnology's website under the following link:
http://www.cytos.com/userfiles/file/Cytos_Q1_2010_E.pdf
Jakob Schlapbach, MBA
Chief Financial Officer
Cytos Biotechnology Ltd
Phone: +41 44 733 46 46
Fax: +41 44 733 47 02
e-Mail: jakob.schlapbach(at)cytos.com
Website: www.cytos.com
22.04.2010 06:45 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv atwww.dgap-medientreff.deandwww.dgap.de---------------------------------------------------------------------------
Language: English
Company: Cytos Biotechnology AG
Wagistr. 25
8952 Schlieren
Schweiz
Phone: +41 44 733 4747
Fax: +41 44 733 4740
E-mail: info(at)cytos.com
Internet: www.cytos.com
ISIN: CH0011025217, CH0029060735
WKN: -
Listed: Freiverkehr in Berlin, München, Stuttgart; Open Market in
Frankfurt; Foreign Exchange(s) SIX
End of News DGAP News-Service
---------------------------------------------------------------------------
Datum: 22.04.2010 - 06:45 Uhr
Sprache: Deutsch
News-ID 19456
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 253 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Cytos Biotechnology Ltd First Quarter Report 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
Cytos Biotechnology AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
